# PMV Tina Fund

> PMV Tina Fund is a VC fund backing Manufacturing, Eyewear and Printing. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Dec 2014
- Lead investor: 20%
- Last updated: Aug 2026

PMV Tina Fund is a venture capital firm that specializes in growth capital investments.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 2 | 40% |
| Eyewear | 1 | 20% |
| Printing | 1 | 20% |
| Wearables | 1 | 20% |
| Industrial | 1 | 20% |

12 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 20% |
| Series D | 1 | 20% |
| Series E | 1 | 20% |
| Series F | 1 | 20% |
| Funding Round | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Belgium | 1 | 20% |
| Switzerland | 1 | 20% |
| The Netherlands | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Borit | Borit delivers components for fuel cells and electrolyzes. By developing a production infrastructure of ultra-thin metal bipolar plate assemblies and by providing metal forming, cutting, welding, coating, and sealing, they contribute to the clean energy economy. | $8.2M |  | Dec 30, 2014 |  |
| Biocartis Group NV | Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $70.8M | Series F | Sep 04, 2014 |  |
| Luxexcel | Luxexcel is the only company in the world with the technology to 3D print lenses. Luxexcel is on a path to open a new era in eyewear with custom quality prescription lenses. And opening up a new vision on smart eyewear by enabling technology partners to develop unique lenses. Luxexcel has developed and owns all components necessary to enable ourcustomers to 3D print optics: hardware, software, process and materials |  | Series A | Dec 01, 2013 |  |
| Biocartis Group NV | Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $32.9M | Series E | Nov 05, 2013 |  |
| Biocartis Group NV | Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexeddetection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland. | $37.8M | Series D | Dec 12, 2012 |  |

5 of 5 investments shown.

## Co-investors
- [Johnson & Johnson Development Corporation](https://shizune.co/investors/profile/johnson-johnson-development-corporation) — VC Fund, 3 deals together
- [RMM](https://shizune.co/investors/profile/rmm) — VC Fund, 2 deals together
- [Debiopharm Group](https://shizune.co/investors/profile/debiopharm) — VC Fund, 1 deal together
- [Debiopharm Innovation Fund](https://shizune.co/investors/profile/debiopharm-innovation-fund) — VC Fund, 1 deal together
- [Filsa Capital](https://shizune.co/investors/profile/filsa-capital) — VC Fund, 1 deal together
- [Finindus](https://shizune.co/investors/profile/finindus) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [Energy Investors in Belgium](https://shizune.co/investors/energy-investors-belgium)
- [Energy VC Funds in Belgium](https://shizune.co/investors/energy-vc-funds-belgium)
- [Sustainability Investors in Belgium](https://shizune.co/investors/sustainability-investors-belgium)
- [Sustainability VC Funds in Belgium](https://shizune.co/investors/sustainability-vc-funds-belgium)
- [Impact Investors in Belgium](https://shizune.co/investors/impact-investors-belgium)
- [Impact VC Funds in Belgium](https://shizune.co/investors/impact-vc-funds-belgium)

## FAQ

### What does PMV Tina Fund invest in?

PMV Tina Fund invests primarily in Manufacturing, Eyewear and Printing startups, most often at Series A and Series D stage. Most of the 5 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did PMV Tina Fund last invest?

The most recent investment recorded for PMV Tina Fund closed in Dec 2014. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co